The University of Chicago Header Logo

Connection

Deric Park to Humans

Back to Details
This is a "connection" page, showing publications Deric Park has written about Humans.
Deric Park
Connection Strength
0.508
Humans
  1. Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK. JCI Insight. 2019 10 17; 4(20).
    View in: PubMed
    Score: 0.023
  2. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma. Cancer Res. 2019 10 15; 79(20):5218-5232.
    View in: PubMed
    Score: 0.022
  3. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Neuro Oncol. 2018 05 18; 20(6):799-809.
    View in: PubMed
    Score: 0.020
  4. Modular peptide-functionalized gold nanorods for effective glioblastoma multicellular tumor spheroid targeting. Biomater Sci. 2018 May 01; 6(5):1140-1146.
    View in: PubMed
    Score: 0.020
  5. LB-100, a novel Protein Phosphatase 2A (PP2A) inhibitor, sensitizes malignant meningioma cells to the therapeutic effects of radiation. Cancer Lett. 2018 02 28; 415:217-226.
    View in: PubMed
    Score: 0.020
  6. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol. 2017 Jul 01; 19(7):887-896.
    View in: PubMed
    Score: 0.019
  7. Cardiac glycosides suppress the maintenance of stemness and malignancy via inhibiting HIF-1a in human glioma stem cells. Oncotarget. 2017 Jun 20; 8(25):40233-40245.
    View in: PubMed
    Score: 0.019
  8. The p38 signaling pathway mediates quiescence of glioma stem cells by regulating epidermal growth factor receptor trafficking. Oncotarget. 2017 May 16; 8(20):33316-33328.
    View in: PubMed
    Score: 0.019
  9. Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma. J Neurooncol. 2016 12; 130(3):571-579.
    View in: PubMed
    Score: 0.018
  10. Isolation and Propagation of Glioma Stem Cells from Acutely Resected Tumors. Methods Mol Biol. 2016; 1516:361-369.
    View in: PubMed
    Score: 0.017
  11. Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. PLoS One. 2015; 10(8):e0134426.
    View in: PubMed
    Score: 0.017
  12. The evidence of glioblastoma heterogeneity. Sci Rep. 2015 Jan 27; 5:7979.
    View in: PubMed
    Score: 0.016
  13. The STAT3-Ser/Hes3 signaling axis in cancer. Front Biosci (Landmark Ed). 2014 01 01; 19(4):718-26.
    View in: PubMed
    Score: 0.015
  14. Diagnosis and treatment of chordoma. J Natl Compr Canc Netw. 2013 Jun 01; 11(6):726-31.
    View in: PubMed
    Score: 0.015
  15. Multiple discrete aneurysmal subarachnoid hemorrhages during multimodality management of a hypothalamic glioma--case report. Clin Neurol Neurosurg. 2013 May; 115(5):632-5.
    View in: PubMed
    Score: 0.014
  16. Chordoma model. J Neurosurg. 2012 Apr; 116(4):799-800; discussion 800.
    View in: PubMed
    Score: 0.013
  17. Improving the radiosensitivity of radioresistant and hypoxic glioblastoma. Future Oncol. 2010 Oct; 6(10):1591-601.
    View in: PubMed
    Score: 0.012
  18. Medical oncology: treatment and management of malignant gliomas. Nat Rev Clin Oncol. 2010 Feb; 7(2):75-7.
    View in: PubMed
    Score: 0.012
  19. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene. 2009 Nov 12; 28(45):3949-59.
    View in: PubMed
    Score: 0.011
  20. Biology of glioma cancer stem cells. Mol Cells. 2009 Jul 31; 28(1):7-12.
    View in: PubMed
    Score: 0.011
  21. Disposition of temozolomide in a patient with glioblastoma multiforme after gastric bypass surgery. J Neurooncol. 2009 Jun; 93(2):279-83.
    View in: PubMed
    Score: 0.011
  22. Identifying Muir-Torre syndrome in a patient with glioblastoma multiforme. Neuro Oncol. 2009 Aug; 11(4):452-5.
    View in: PubMed
    Score: 0.011
  23. N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle. 2007 Feb 15; 6(4):467-70.
    View in: PubMed
    Score: 0.009
  24. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells. PLoS Med. 2007 Feb; 4(2):e60.
    View in: PubMed
    Score: 0.009
  25. Delayed infection of the Ommaya reservoir. Neurology. 2002 Sep 24; 59(6):956-7.
    View in: PubMed
    Score: 0.007
  26. Pharmacotherapy of primary CNS lymphoma. Expert Opin Pharmacother. 2002 Jan; 3(1):39-49.
    View in: PubMed
    Score: 0.007
  27. Pediatric Gliomas Presenting with Gliomatosis-Like Spread, Lack of Contrast Enhancement, EGFR Mutation, and TERT Promoter Variants. J Neuropathol Exp Neurol. 2021 12 29; 80(12):1134-1136.
    View in: PubMed
    Score: 0.007
  28. Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma. Oncologist. 2021 05; 26(5):e847-e858.
    View in: PubMed
    Score: 0.006
  29. Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
    View in: PubMed
    Score: 0.006
  30. An atypical presentation of primary central nervous system lymphoma: A case report. Medicine (Baltimore). 2020 Sep 18; 99(38):e22062.
    View in: PubMed
    Score: 0.006
  31. Combination of PARP inhibitor and temozolomide to suppress chordoma progression. J Mol Med (Berl). 2019 08; 97(8):1183-1193.
    View in: PubMed
    Score: 0.006
  32. Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery. FASEB J. 2019 08; 33(8):9235-9249.
    View in: PubMed
    Score: 0.006
  33. Cytokine Microdialysis for Real-Time Immune Monitoring in Glioblastoma Patients Undergoing Checkpoint Blockade. Neurosurgery. 2019 04 01; 84(4):945-953.
    View in: PubMed
    Score: 0.005
  34. Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2019 04 01; 25(7):2305-2313.
    View in: PubMed
    Score: 0.005
  35. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer. 2018 06 11; 6(1):51.
    View in: PubMed
    Score: 0.005
  36. Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3? in oncocytomas. J Pathol. 2018 07; 245(3):361-372.
    View in: PubMed
    Score: 0.005
  37. Clinical decision making in the era of immunotherapy for high grade-glioma: report of four cases. BMC Cancer. 2018 03 01; 18(1):239.
    View in: PubMed
    Score: 0.005
  38. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition. EMBO Rep. 2017 01; 18(1):150-168.
    View in: PubMed
    Score: 0.005
  39. The functional interplay between systemic cancer and the hematopoietic stem cell niche. Pharmacol Ther. 2016 12; 168:53-60.
    View in: PubMed
    Score: 0.005
  40. Glioma in Patients with Autosomal-Dominant Polycystic Kidney Disease. World Neurosurg. 2017 Feb; 98:885.e1-885.e5.
    View in: PubMed
    Score: 0.005
  41. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. PLoS One. 2014; 9(3):e91546.
    View in: PubMed
    Score: 0.004
  42. Identification of repurposed small molecule drugs for chordoma therapy. Cancer Biol Ther. 2013 Jul; 14(7):638-47.
    View in: PubMed
    Score: 0.004
  43. CNTF receptor subunit a as a marker for glioma tumor-initiating cells and tumor grade: laboratory investigation. J Neurosurg. 2012 Dec; 117(6):1022-1031.
    View in: PubMed
    Score: 0.003
  44. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. J Neurosurg. 2012 May; 116(5):972-7.
    View in: PubMed
    Score: 0.003
  45. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions. Cell Death Dis. 2011 Sep 01; 2:e200.
    View in: PubMed
    Score: 0.003
  46. The effect of a PP2A inhibitor on the nuclear receptor corepressor pathway in glioma. J Neurosurg. 2010 Aug; 113(2):225-33.
    View in: PubMed
    Score: 0.003
  47. Cholera toxin regulates a signaling pathway critical for the expansion of neural stem cell cultures from the fetal and adult rodent brains. PLoS One. 2010 May 26; 5(5):e10841.
    View in: PubMed
    Score: 0.003
  48. Angiogenic factors stimulate growth of adult neural stem cells. PLoS One. 2010 Feb 26; 5(2):e9414.
    View in: PubMed
    Score: 0.003
  49. Comparison of multidimensional shotgun technologies targeting tissue proteomics. Electrophoresis. 2009 Dec; 30(23):4063-70.
    View in: PubMed
    Score: 0.003
  50. Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg. 2007 Jul; 107(1):190-7.
    View in: PubMed
    Score: 0.002
  51. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B. Endocr Relat Cancer. 2007 Jun; 14(2):463-71.
    View in: PubMed
    Score: 0.002
  52. Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology. 2007 Jan 23; 68(4):254-61.
    View in: PubMed
    Score: 0.002
  53. Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers. Neurology. 2006 Mar 14; 66(5):733-6.
    View in: PubMed
    Score: 0.002
  54. Identification of tumor precursor cells in the brains of primates with radiation-induced de novo glioblastoma multiforme. Cell Cycle. 2006 Feb; 5(4):452-6.
    View in: PubMed
    Score: 0.002
  55. HLA-DRB5*0101 and -DRB1*1501 expression in the multiple sclerosis-associated HLA-DR15 haplotype. J Neuroimmunol. 2005 Oct; 167(1-2):108-19.
    View in: PubMed
    Score: 0.002
  56. How do patients want physicians to handle mistakes? A survey of internal medicine patients in an academic setting. Arch Intern Med. 1996 Dec 9-23; 156(22):2565-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.